https://news.augustaheadlines.com/story/573258/chronic-rhinosinusitis-with-nasal-polyps-clinical-trial-pipeline-gains-momentum-8-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight.html 2026-04-29T23:48:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/573206/the-giuliani-law-firm-flags-surge-in-las-vegas-probate-disputes-linked-to-poor-estate-planning.html 2026-04-29T23:48:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/573257/cutaneous-squamous-cell-carcinoma-clinical-trial-pipeline-appears-robust-with-45-key-pharma-companies-actively-working-in-the-domain-delveinsight.html 2026-04-29T23:36:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/573256/atopic-dermatitis-clinical-trial-pipeline-appears-robust-with-100-key-pharma-companies-actively-working-in-the-domain-delveinsight.html 2026-04-29T23:30:06+00:00 daily 1.0 https://news.augustaheadlines.com/story/573255/dry-eye-disease-clinical-trial-pipeline-appears-robust-with-50-key-pharma-companies-actively-working-in-the-domain-delveinsight.html 2026-04-29T23:24:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/573254/plaque-psoriasis-treatment-pipeline-shows-strong-momentum-as-75-pharma-companies-in-the-race-delveinsight.html 2026-04-29T23:16:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/573253/autosomal-dominant-polycystic-kidney-disease-clinical-trial-pipeline-expands-as-13-companies-driving-innovation-in-the-therapeutics-delveinsight.html 2026-04-29T23:10:05+00:00 daily 1.0 https://news.augustaheadlines.com/story/573252/tenosynovial-giant-cell-tumors-clinical-trial-pipeline-accelerates-as-5-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight.html 2026-04-29T23:04:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/573251/myasthenia-gravis-clinical-trial-pipeline-shows-potential-with-active-contributions-from-25-key-companies-delveinsight.html 2026-04-29T22:58:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/573250/nonalcoholic-steatohepatitis-pipeline-set-for-transformational-expansion-by-2026-with-75-therapies-strong-clinical-momentum-from-novo-nordisk-viking-therapeutics-inventiva-pharma-delveinsight.html 2026-04-29T22:48:04+00:00 daily 1.0